Proteomics International Laboratories Ltd (ASX:PIQ)
Australia · Delayed Price · Currency is AUD 0.1300
-0.0100 (-7.14%)
Sep 18, 2026, 4:10 PM AEST
ASX:PIQ Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 0.28 | 0.59 | 0.89 | 0.73 | 1.49 |
Other Revenue | 3.09 | 2.73 | 2.38 | 2.45 | 1.94 |
| 3.37 | 3.31 | 3.27 | 3.18 | 3.43 | |
Revenue Growth | 1.75% | 1.34% | 2.75% | -7.26% | 25.39% |
Cost of Revenue | 1.48 | 2.11 | 2.02 | 2.35 | 2.06 |
Gross Profit | 1.89 | 1.2 | 1.25 | 0.84 | 1.37 |
Selling, General & Admin | 8.43 | 7.05 | 5.88 | 5.82 | 4.91 |
Other Operating Expenses | 0.95 | 1.02 | 0.61 | 0.53 | 0.51 |
Operating Expenses | 10.69 | 9.47 | 8 | 7.2 | 6.35 |
Operating Income | -8.79 | -8.27 | -6.75 | -6.37 | -4.98 |
Interest Expense | -0.04 | -0.04 | -0.02 | - | -0 |
Interest & Investment Income | 0.24 | 0.2 | 0.28 | 0.14 | 0.01 |
Currency Exchange Gain (Loss) | -0.02 | -0.04 | -0.01 | -0.02 | 0 |
EBT Excluding Unusual Items | -8.61 | -8.15 | -6.5 | -6.25 | -4.97 |
Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.01 | - |
Pretax Income | -8.61 | -8.15 | -6.48 | -6.23 | -4.97 |
Earnings From Continuing Operations | -8.61 | -8.15 | -6.48 | -6.23 | -4.97 |
Minority Interest in Earnings | 0.05 | 0.04 | 0.11 | 0.06 | - |
Net Income | -8.56 | -8.11 | -6.38 | -6.18 | -4.97 |
Net Income to Common | -8.56 | -8.11 | -6.38 | -6.18 | -4.97 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 134 | 126 | 126 | 116 | 106 |
Shares Outstanding (Diluted) | 134 | 126 | 126 | 116 | 106 |
Shares Change | 6.69% | - | 8.07% | 10.35% | 3.76% |
EPS (Basic) | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 |
EPS (Diluted) | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -7.88 | -6.63 | -6 | -6.91 | -3.67 |
Free Cash Flow Per Share | -0.06 | -0.05 | -0.05 | -0.06 | -0.04 |
Gross Margin | 56.09% | 36.20% | 38.34% | 26.27% | 40.01% |
Operating Margin | -260.96% | -249.57% | -206.46% | -200.11% | -145.10% |
Profit Margin | -253.98% | -244.98% | -195.08% | -194.17% | -144.98% |
Free Cash Flow Margin | -233.87% | -200.28% | -183.46% | -217.25% | -106.97% |
EBITDA | -8.13 | -7.79 | -6.12 | -5.84 | -4.56 |
EBITDA Margin | -241.28% | -235.19% | -187.28% | -183.46% | -132.95% |
D&A For EBITDA | 0.66 | 0.48 | 0.63 | 0.53 | 0.42 |
EBIT | -8.79 | -8.27 | -6.75 | -6.37 | -4.98 |
EBIT Margin | -260.95% | -249.57% | -206.46% | -200.11% | -145.10% |
Revenue as Reported | 3.61 | 3.51 | 3.57 | - | - |